SYNTHETIC BIOLOGICS INC (SYN) Stock Analyst Earnings Estimates
NYSEARCA:SYN - NYSE Arca - US87164U4094 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | |||||||||
| EBITDA YoY % growth | -20.482M | -40.908M -99.73% | -39.095M 4.43% | -26.006M 33.48% | -17.299M 33.48% | -15.423M 10.84% | -9.959M 35.43% | -14.187M -42.45% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -20.502M | -40.98M -99.88% | -39.252M 4.22% | -26.251M 33.12% | -17.571M 33.07% | -15.663M 10.86% | -10.16M 35.13% | -14.274M -40.49% | N/A -41.88% | N/A -27.13% | N/A -26.36% | N/A 27.47% | N/A 26.75% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -11.20 | -17.50 -56.25% | -10.15 42.00% | -5.95 41.38% | -3.00 49.58% | -2.64 12.00% | -6.10 -131.06% | -2.10 65.57% | N/A 38.44% | N/A -12.11% | N/A 26.83% | N/A -6.30% | N/A -7.36% |
All data in USD
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.33 -66.65% | -0.34 15.41% | -0.30 -1.00% | -0.30 2.26% | -0.33 | -0.31 7.46% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.352M -63.43% | -5.57M -5.80% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -0.31 -55.00% | -0.35 | 0.04 | 12.31% |
| Q1 2022 Q2Q % growth | -0.30 76.92% | -0.30 | 0.00 | 0.99% |
| Q4 2021 Q2Q % growth | -0.40 71.43% | -0.30 | -0.10 | -32.01% |
| Q3 2021 Q2Q % growth | -0.20 85.71% | -0.25 | 0.05 | 20.79% |
| Q2 2021 Q2Q % growth | -0.20 87.50% | -0.20 | 0.00 | 0.99% |
| Q1 2021 Q2Q % growth | -1.30 23.53% | -0.20 | -1.10 | -543.56% |
| Q4 2020 Q2Q % growth | -1.40 26.32% | -0.81 | -0.59 | -73.27% |
| Q3 2020 Q2Q % growth | -1.40 -366.67% | -1.72 | 0.32 | 18.46% |
| Q2 2020 Q2Q % growth | -1.60 -627.27% | -1.62 | 0.02 | 0.99% |
| Q1 2020 Q2Q % growth | -1.70 -672.73% | -2.73 | 1.03 | 37.66% |
| Q4 2019 Q2Q % growth | -1.90 | -2.32 | 0.42 | 18.21% |
| Q3 2019 Q2Q % growth | -0.30 | -0.23 | -0.07 | -29.14% |
| Q2 2019 Q2Q % growth | -0.22 | -0.23 | 0.01 | 5.29% |
| Q1 2019 Q2Q % growth | -0.22 | -0.23 | 0.01 | 5.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |